Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3

Watchlist Manager
Oncoclinicas do Brasil Servicos Medicos SA Logo
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Watchlist
Price: 7.07 BRL 10.47% Market Closed
Updated: May 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

9.2B
+7%
Assets
Growth Rates:
1 Year
+12%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
6.9B
+8%
Liabilities
Growth Rates:
1 Year
+13%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
2.3B
+4%
Equity
Growth Rates:
1 Year
+9%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Oncoclinicas do Brasil Servicos Medicos SA

9.2B
Assets
6.9B
Liabilities
9.2B
Assets
6.9B
Liabilities
Current Assets 3.1B
Cash & Short-Term Investments 761.4m
Receivables 2.1B
Other Current Assets 279.9m
Non-Current Assets 6.1B
Long-Term Investments 106.2m
PP&E 1.2B
Intangibles 4.2B
Other Non-Current Assets 543.8m
Current Liabilities 1.8B
Accounts Payable 957.5m
Accrued Liabilities 281.3m
Other Current Liabilities 577.7m
Non-Current Liabilities 5.1B
Long-Term Debt 4.1B
Other Non-Current Liabilities 982.2m

Balance Sheet
Oncoclinicas do Brasil Servicos Medicos SA

Rotate your device to view
Balance Sheet
Currency: BRL
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
199
447
741
537
263
551
Cash
14
29
17
49
46
59
Cash Equivalents
185
419
724
488
218
492
Short-Term Investments
0
0
46
1 478
830
211
Total Receivables
372
492
561
763
1 522
2 064
Accounts Receivables
314
417
481
666
1 380
1 857
Other Receivables
58
76
80
97
143
207
Inventory
16
19
37
69
164
206
Other Current Assets
26
25
27
24
48
74
Total Current Assets
613
983
1 412
2 871
2 827
3 105
PP&E Net
260
438
614
729
1 091
1 235
PP&E Gross
0
0
614
729
1 091
1 235
Accumulated Depreciation
0
0
162
251
401
449
Intangible Assets
106
204
596
1 069
1 350
1 521
Goodwill
294
415
613
1 169
2 564
2 670
Note Receivable
31
18
19
31
32
8
Long-Term Investments
1
10
33
37
34
106
Other Long-Term Assets
44
41
76
125
321
536
Other Assets
294
415
613
1 169
2 564
2 670
Total Assets
1 348
N/A
2 110
+57%
3 363
+59%
6 032
+79%
8 220
+36%
9 181
+12%
Liabilities
Accounts Payable
258
344
455
511
1 090
957
Accrued Liabilities
104
122
171
169
205
281
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
72
419
272
396
403
474
Other Current Liabilities
14
31
115
115
185
103
Total Current Liabilities
447
916
1 014
1 191
1 883
1 816
Long-Term Debt
326
416
1 359
2 034
3 071
4 081
Deferred Income Tax
8
15
2
6
6
22
Minority Interest
87
100
277
451
515
378
Other Liabilities
97
106
311
496
626
582
Total Liabilities
965
N/A
1 554
+61%
2 963
+91%
4 178
+41%
6 102
+46%
6 880
+13%
Equity
Common Stock
374
400
416
2 103
2 145
2 339
Retained Earnings
127
337
177
233
437
672
Unrealized Security Profit/Loss
118
180
193
481
465
710
Total Equity
383
N/A
557
+45%
400
-28%
1 854
+364%
2 118
+14%
2 301
+9%
Total Liabilities & Equity
1 348
N/A
2 110
+57%
3 363
+59%
6 032
+79%
8 220
+36%
9 181
+12%
Shares Outstanding
Common Shares Outstanding
495
495
496
496
495
508

See Also

Summary
ONCO3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
ONCO3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ONCO3 stock valuation using valuation multiples.
Wall Street Estimates
ONCO3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ONCO3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.